India, Dec. 22 -- Researchers from Indian Institute of Technology Madras (IIT Madras), Monash University and Deakin University, Australia, have developed a cutting-edge nanoinjection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.

The approach creates a precise and sustained therapeutic system that minimises damage to healthy cells by combining nanoarchaeosome-based drug encapsulation with silicon nanotube (SiNT)-based intracellular delivery.

Breast cancer remains one of the leading causes of mortality among women worldwide. Conventional treatments such as chemotherapy and radiation often harm non-cancerous tissues due to systemic drug exposure.

To overcome these limitations, the ...